As expected, USP22 deficiency dramatically impaired Treg suppressive function but increased the proportion of IFN-γ+GrB+ CD8+ T cells and significantly inhibited tumor growth in multiple cancer models [86]. The gene discussed is CD8A; the disease is neoplasm.